ArticlePloS one2016

Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).

Keisuke Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.